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Background: Chronic fatigue and inactivity are prevalent problems among individuals with multiple sclerosis (MS)
and may independently or interactively have detrimental effects on quality of life and ability to participate in life
roles. However, no studies to date have systematically evaluated the benefits of an intervention for both managing
fatigue and promoting physical activity in individuals with MS. This study involves a randomized controlled trial to
examine the effectiveness of a telehealth intervention that supports individuals with MS in managing fatigue and
increasing physical activity levels.
Methods/Design: A randomly-allocated, three-parallel group, time-series design with a social support program
serving as the control group will be used to accomplish the purpose of the study. Our goal is to recruit 189
ambulatory individuals with MS who will be randomized into one of three telehealth interventions: (1) a
contact-control social support intervention, (2) a physical activity-only intervention, and (3) a physical activity plus
fatigue management intervention. All interventions will last 12 weeks and will be delivered entirely over the phone.
Our hypothesis is that, in comparison to the contact-control condition, both the physical activity-only intervention
and the physical activity plus fatigue management intervention will yield significant increases in physical activity
levels as well as improve fatigue and health and function, with the physical activity plus fatigue management
intervention yielding significantly larger improvements. To test this hypothesis, outcome measures will be
administered at Weeks 1, 12, and 24. Primary outcomes will be the Fatigue Impact Scale, the Godin Leisure-Time
Exercise Questionnaire (GLTEQ), and Actigraph accelerometers. Secondary outcomes will include the SF-12 Survey,
Mental Health Inventory, Multiple Sclerosis Impact Scale, the Community Participation Indicator, and psychosocial
constructs (e.g., self-efficacy).
Discussion: The proposed study is novel, in that it represents a multi-disciplinary effort to merge two promising
lines of research on MS: fatigue management and physical activity promotion. Collectively, the proposed study will
be the largest randomized controlled trial to examine the effects of a lifestyle physical activity intervention in
people with MS.
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Multiple sclerosis (MS) is an immune-mediated neuro-
logical disease that results in a variety of conse-
quences, most notably fatigue and physical inactivity.
In fact, 75-90% of people with MS report having fa-
tigue, and 60% describe it as their most disabling
symptom [1-5]. Beyond fatigue, persons with MS are
highly inactive compared with matched controls [6],
and this inactivity may increase the risk of developing
secondary conditions (e.g., obesity, heart disease, and
diabetes) that can accelerate MS-related functional de-
cline [7]. We further note that fatigue and physical in-
activity may create a cyclical pattern of functional
decline over time [8].
One approach for managing fatigue and physical in-
activity involves the development of behavioral inter-
ventions that focus on teaching self-management tasks
and skills [9]. For example, a randomized controlled
trial (RCT) indicated that a fatigue self-management
teleconference program was significantly more effective
than a delayed-treatment control group for reducing fa-
tigue impact and improving certain dimensions of
health-related quality of life in persons with MS [10].
The changes were maintained for six months after the
intervention. Another RCT demonstrated that a behav-
ioral intervention delivered via the Internet was effect-
ive in promoting and sustaining physical activity
behavior change in ambulatory adults with MS [11],
and this effect was seemingly mediated by self-
regulatory strategies of self-monitoring and goal-setting
[12].
To date, interventions for managing fatigue and phys-
ical inactivity have typically been addressed as separate
lines of research, even though these two common conse-
quences of MS are likely interrelated [6,13,14]. The re-
ciprocal relationship between fatigue and inactivity may
accelerate a cycle of functional decline [15]. MS fatigue
can decrease motivation to engage in physical activity
[16,17]. Inactivity is associated with de-conditioning,
mobility problems, depression, and further fatigue [18-
21], which makes it even more difficult to engage in
physical activity [22]. No study to date has systematically
explored the combined benefits of teaching fatigue man-
agement strategies and promoting physical activity. We
also note that the population with MS may have limited
access to health professionals who can adequately ad-
dress problems related to fatigue and inactivity, particu-
larly for those who reside in rural communities [23,24].
Therefore, using a telehealth approach to address the
reciprocal relationship between MS fatigue and inactiv-
ity could increase the intervention’s accessibility and
dissemination.
The objective of this proposed study is to conduct a
RCT to examine the effectiveness of a telehealthintervention that supports individuals in managing fa-
tigue and increasing physical activity levels. The pro-
posed study is novel in that it represents a multi-
disciplinary effort to merge two promising lines of re-
search on MS: fatigue management and physical activity
promotion. The proposed fatigue management plus
physical activity intervention (FM+) will consist of in-
corporating a teleconference fatigue management inter-
vention informed by the work of Packer et al. [25],
Finlayson et al. [10], and Mathiowetz et al.[26] with a
novel, yet simple approach to promote lifestyle physical
activity, i.e., encouraging goal-setting and self-
monitoring with a pedometer. Our goal is to recruit
189 ambulatory individuals with MS who will be rando-
mized into one of three telehealth interventions: (1) a
contact-control social support intervention, (2) a phys-
ical activity-only intervention, and (3) a FM + interven-
tion. Below we outline the aims, outcome measures,
and associated hypotheses of the study.
Specific aim 1
The first aim is to compare the effects of the three
interventions on fatigue impact and physical activity
levels. Outcomes will be the Fatigue Impact Scale
(FIS) [27], the Godin Leisure-Time Exercise Question-
naire (GLTEQ) [28], and Actigraph accelerometers.
Our hypothesis is that, in comparison to the contact-
control condition, both interventions will yield signifi-
cant improvements in FIS scores and physical activity
levels, with the FM+ yielding significantly larger
improvements.
Specific aim 2
The second aim is to compare the effects of the three
interventions on health-related quality of life, mental
health, and participation in life roles. Outcomes will be
the SF-12, Mental Health Inventory (MHI), Multiple
Sclerosis Impact Scale (MSIS) [29,30], and the Commu-
nity Participation Indicator (CPI) [31,32]. Our hypothesis
is that, in comparison to the contact-control condition,
both interventions will yield a significant increase in SF-
12, MHI, MSIS, and CPI scores, with the FM + yielding
a significantly larger increase.
Specific aim 3
The third aim is to identify potential mediators of the
interventions. Psychosocial constructs measures related
to fatigue and physical activity (e.g., self-efficacy, goal-
setting, and outcome expectations) will be administered
to help identify the underlying mechanisms of the inter-
ventions’ possible effectiveness. Our hypothesis is that
scores on these measures will significantly improve, and
that improvements will explain the interventions’ effect
on fatigue and physical activity.
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A randomly-allocated, three-parallel group, time-series
design with a social support program serving as the con-
trol group will be used to accomplish the aims of the
study. Outcome measures will be administered at Weeks
1, 12, and 24. All interventions will involve a 12-week
intervention period (three or six teleconference sessions
weekly, and four one-to-one phone calls every other
week) followed by a 12-week non-contact period to de-
termine whether the effects persist. The design will en-
able us to compare the overall immediate and sustained
outcomes of the three interventions. The protocol is
approved by the Cleveland Clinic’s Institutional Review
Board (ref: 11-844) in accordance with the Declaration
of Helsinki. The study is funded by the National Mul-
tiple Sclerosis Society.
Sample size
In order to achieve an adequate power of 0.80 to test hy-
potheses, we will seek to recruit a total of 189 indivi-
duals for this study and, more specifically, 63 in each
condition. The total number of individuals to be
recruited is based on calculations of sample size and
power for a balanced repeated-measure mixed effect
model with three time points (Weeks 1, 12, and 24)
using a formula provided by Hedeker et al. [33]. We
assumed equal variance and correlation (rho = 0.5) be-
tween measures across time points, and an effect size of
0.6 at Weeks 12 and 24. These calculations account for
20% attrition over time.
Recruitment and eligibility
Individuals for this study will be recruited in several dif-
ferent ways in the State of Ohio. We have restricted re-
cruitment to Ohio to avoid complications with state
licensure laws. Fliers for the study will be distributed
through MS support groups and National MS Society
and MS Association of America events. We will recruit
through physician referral and electronic health record
review, and an MS patient registry maintained by the
North American Research Consortium on MS (NAR-
COMS), which has approximately 400 registered indivi-
duals in Ohio who are ambulatory. Regardless of the
recruitment method, individuals who are interested in
participating in the study will be asked to contact the
study office. Potential participants will undergo a tele-
phone screening procedure to determine eligibility, and
then a confirmation of eligibility through contacting
their physician.
Inclusion criteria are: (1) physician-confirmed diagno-
sis of MS and physician-consent to initiate a physical ac-
tivity program, (2) age between 18 and 65 years, (3)
ability to walk at least 25 feet with a cane, (4) ability to
carry on telephone conservations in English, (5) aPatient Determined Disease Step score between 1 (mild
disability) and 5 (unilateral support required) [34], (6) a
current sedentary lifestyle (i.e., purposeful exercises ≤
2 days per week for 30 minutes) [35], and (7) experi-
ences moderate to severe fatigue (a score of ≥ 4 on the
Fatigue Severity Scale) [36]. Exclusion criteria are: (1)
pregnancy, (2) cardiopulmonary diseases, (3) uncon-
trolled diabetes (hospitalized within the last six months),
(4) greater than three falls in the past six months, and
(5) severe cognitive deficits (weighted score of less than
12 on the short version of the Blessed Orientation Mem-
ory Concentration test) [37].
Random allocation procedures
Randomization will be performed using a random per-
mutated block design. The allocation will be performed
using a random number generator. Three persons will
be assigned to each block. The first person in the block
will have an equal probability of being randomized into
any of the three conditions. The second person will be
randomized into one of the two remaining conditions
and the third person in the block will automatically be




This intervention will consist of three group teleconfer-
ence sessions and four one-to-one calls. The overall pur-
pose of the group teleconferencing will be to teach
people how to engage in physical activity and set perso-
nalized goals to increase physical activity. The overall
purpose of the one-to-one telephone calls will be to pro-
vide feedback and encouragement on achieving physical
activity goals. Participants will first receive the three
one-hour weekly group teleconference sessions from a
licensed occupational therapist (OT). We selected OTs
to deliver the teleconference sessions because of their
expertise and training in managing group processes to
facilitate behavior change. Participants will also be pro-
vided with four 10 to 20-minute, one-to-one, structured,
follow-up telephone calls with a graduate assistant every
other week. Both the group teleconference sessions and
one-to-one follow-up telephone calls will be consistent
with goal-setting theory [38] and increasing self-efficacy
using verbal persuasion, teaching how to set measurable
and reasonable goals, proving feedback on goals, and
using role modeling (e.g., group members sharing stor-
ies) [39].
The first intervention session will focus on discussing
the safety precautions for and benefits of physical activ-
ity specifically for persons with MS, and then teaching
participants how to use a pedometer to monitor physical
activity levels. Homework will be assigned to self-
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erate a baseline level of physical activity for subsequent
goal-setting. The second session will focus on using the
pedometer to set goals. Participants will be encouraged
to achieve personal goals related to the accumulation
of pedometer steps by at least 1% every week. Partici-
pants will have the option to set additional goals
related to exercise, which they can keep track of in
their exercise log. Homework will be assigned to set
personalized physical activity goals. The final session
will focus on the personalized goals, and feedback from
the OT and other group members on the appropriate-
ness of goals. There will be a discussion and summary
of the guiding principles that will help persons with
MS safely engage in physical activity and overcoming
barriers to engagement. The one-to-one follow-up tele-
phone calls will focus on providing feedback on phys-
ical activity goals. Goals will be reviewed and adjusted
biweekly under the guidance of a trained research as-
sistant. The aim will be to teach the participant how to
set and adjust goals independently.
FM+ intervention
Participants randomized into this intervention will first
receive the three goal-setting physical activity teleconfer-
ence sessions with the OT, and then will receive three
additional teleconference sessions on fatigue manage-
ment principles with the same OT. Thus, participants
will receive a total of six group teleconference sessions.
The participants will start to receive the four one-to-one
calls from the research assistant after the completion of
the first three session. For the purpose of this study, we
will only teach fatigue management principles that can
be integrated into the focus of changing physical activity
behavior. This will include topics emphasizing the im-
portance of rest throughout the day, setting priorities,
activity analysis and modification, and living a balanced
lifestyle. The first FM+ session will focus on teaching
the guiding principles of fatigue management, and dis-
cussing the fatigue cycle and how inactivity and decondi-
tioning can make fatigue worse. The second FM +
section will focus on evaluating priorities, making active
decisions, and using rest strategically in order to have
adequate energy to engage in physical activity. The third
FM + session will focus on teaching participants how to
analyze and modify their schedules in order to manage
their fatigue and achieve physical activity goals.
Contact-control social support intervention
The contact control group will consist of the same num-
ber of contacts as the FM+, i.e., six weekly one-hour
teleconference calls with four biweekly one-to-one
phone calls. Thus, this condition will allow us to deter-
mine whether it is the actual content being taught in thegoal-setting physical activity intervention and FM+
intervention that is beneficial, rather than simply the
contacts with the OT or social support provided by
other group members. The teleconference calls and the
one-to-one calls will involve a discussion of topics com-
monly addressed in support groups. Topics will include
information on MS, disease modifying medications, pre-
ventive screening, community organizations, nutrition
and supplements, cognitive problems, and recognizing
symptoms of depression and chronic stress. For the tele-
conference sessions, participants will be given the oppor-
tunity to share problems and provide peer support and
solutions for others. For the one-to-one calls, partici-
pants will be asked about topics of interest, and the
graduate student will gather educational materials and
send them to the participant. This information will be
the basis for the discussion in the calls. When issues
related to fatigue and physical activity are raised, partici-
pants will be directed to publically available educational
pamphlets. This type of social support group has been
used successfully in other clinical trials as a control con-
dition to evaluate the efficacy of fatigue management
programs in persons with MS [40].
Ensuring the fidelity of the interventions Guidelines
suggested by Bellg [41] will be implemented to promote
uniform application of all three interventions. For ex-
ample, a manual of operating procedures will be pro-
vided to interventionists and incorporated into training.
Interventionists’ adherence to the intervention protocol
will be verified using a checklist and episodic monitoring
of the sessions over the phone. Fidelity of the interven-
tion “dose” will be further monitored by tracking attend-
ance for each session, monitoring the completion of
worksheets, and testing comprehension.
Primary dependent variables All dependent variables
will be administered at baseline, at the end of the 12-
week intervention period, and at a 24-week follow-up
period through the mail.
Fatigue impact will be measured using the Fatigue Im-
pact Scale [27]. This 40-item scale evaluates the per-
ceived impact of fatigue on everyday life, and is valid
and reliable among people with MS. It was developed by
interviewing patients with MS, and has discriminant val-
idity between patients with MS, general fatigue, and es-
sential hypertension [27]. Respondents rate each
statement using a five-point Likert-type scale ranging
from 0 (no problem) to 4 (extreme problem). A total
score and three subscale scores (physical, social, cogni-
tive) can be produced from participants responses. The
FIS was used to detect changes in fatigue impact result-
ing from a fatigue management teleconference program
[10].
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Leisure-Time Exercise Questionnaire (GLTEQ) [28] and
an Actigraph tri-axis accelerometer. The GLTEQ is a
self-administered measure of usual physical activity. The
GLTEQ includes three items that measure the frequency
of strenuous, moderate, and mild exercise for periods of
more than 15 minutes during one’s free time in a typical
week. Participants will be sent an accelerometer to wear
daily over three seven-day periods (baseline, post-test,
and follow-up). Data are retrieved for analysis via a com-
puter and software provided with the unit. We will use
an epoch of one minute. Participants will be instructed
to wear the accelerometers all day, except while shower-
ing and swimming, for each of the three seven-day
measurement periods. The participant will use a log to
record the time that the accelerometer is worn, and this
will be verified by inspection of the minute-by-minute
accelerometer data. Motl et al. have demonstrated the
validity and reliability of both the GLTEQ and the accel-
erometer in the population with MS [42].
Secondary dependent variables Health-related quality
of life, mental health, and participation in life roles will
be measured with the SF-12, Mental Health Inventory,
and Community Participation Indicator (CPI), respect-
ively. The SF-12 and Mental Health Inventory are valid
and reliable measures, and are commonly used in the
population with MS [43]. The CPI is a new measure
developed by Heinemann and colleagues. The measure
was developed with input from multiple stakeholders,
and has been validated through Rasch analysis in a sam-
ple of 1,163 individuals with a variety of disabling condi-
tions [31,32]. In a subsequent online survey study, the
measure had good test-retest reliability over a 2.5 month
period in people with MS (t = 0.12, p = 0.91; r = 0.84, p <
0.01). For each item, respondents rate the frequency of
engagement (either in days, hours, or times per week,
depending on the type of activity), whether it was im-
portant (yes/no), and whether they were doing it not
enough, enough, or too much. Examples of the 20 items
included are: work for money, provide care for a loved
one, volunteer, and participate in learning activities.
Six questionnaires will be implemented to identify
underlying mechanisms of the interventions’ possible ef-
fectiveness for increasing physical activity levels and re-
ducing fatigue impact. Psychosocial construct measures
for physical activity will be the Self-Efficacy for Exercise
Scale [44], Exercise Goal-Setting Scale [12,45], and
Multidimensional Outcome Expectations Scale [46]. All
three questionnaires are validated and have been used in
previous MS research on physical activity [45,47]. Psy-
chosocial construct measures for fatigue management
will be the validated Self-Efficacy for Performing Energy
Conservation Strategies [48] along with two additionalmeasures on goal-setting and outcome expectations,
which will be developed and validated during the study.
To address potential confounders on the interventions’
effects, information will be collected from participants
for the purposes of post-hoc sub-group comparisons and
potential use as control variables. These variables will in-
clude age, sex, educational level, medications, exacerba-
tions, functional level, and involvement in any other
wellness, rehabilitation, or exercise program. Informa-
tion about changes in MS-related disability, exacerba-
tions, medications, use of rehabilitation programs and
other types of exercise/educational programs, and rea-
sons for attrition will be gathered over the phone at
12 weeks and at the 24-week follow-up.
Data management and analysis A secure online appli-
cation, Research Electronic Data Capture [49], will be
used to manage recruitment efforts and facilitate data
collection. The first step in the analysis process will be
to compute summary statistics, calculate outcome
scores, and conduct quality control assessments. The
second step in the analysis will be to test whether the
randomization process resulted in equivalent groups at
baseline. If differences are found at baseline, these vari-
ables will be used as covariates during the hypothesis
testing phase. The third step in the analysis process will
be addressing normality assumptions, and the potential
for missing data, before hypothesis testing begins. If the
normality assumption is violated, then an appropriate
data transformation will be used. Missing data will be
treated conservatively. If appropriate, maximum likeli-
hood, multiple imputation, or last observation carried
forward will be used to estimate the missing values.
After addressing issues of attrition and missing data, the
fourth step will be to conduct intent-to-treat analysis to
test the hypotheses. Linear mixed-effects models will be
used as the primary analysis tool for testing hypotheses,
which include condition, time, and interactions as the
fixed covariates, and a random intercept that models the
correlation among outcomes collected from the same
subject. The mixed models will allow us to determine
whether there are significant differences between the
three conditions and whether there are significant differ-
ences across time. All tests will be two-sided, and p =
0.05 will serve as the criterion for significance. As is typ-
ically the case for mixed-effects analyses, the results will
not be controlled for multiple comparisons. The general-
ized estimating equation approaches will be used if the
normality distributional assumption is violated for the
random effects in the mixed models. To test for medi-
ation, we will use a linear regression model. This analysis
will first involve regressing changes in fatigue impact or
physical activity on the intervention conditions, and then
regressing changes in fatigue or physical activity on the
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mediator. Mediation will be based on the interventions’
association with physical activity or fatigue impact being
reduced in magnitude and non-significant after control-
ling for the mediator variable.
Discussion
Possibly the most overlooked determinant of a poor
quality of life and participation restrictions in adults with
MS involves the cyclical relationship between fatigue
and inactivity, and the subsequent development of sec-
ondary conditions. Research indicates that fatigue is a
common and profound barrier to engaging in physical
activity among persons with MS [16,17], and that in-
activity is related to functional decline [50]. Further-
more, in a recent longitudinal study, Motl et al. [18]
demonstrated that changes in both fatigue and depres-
sive symptoms are significantly associated with reduced
physical activity levels. Finally, we note that many stud-
ies indicate that MS fatigue and inactivity negatively
affect quality of life and participation in life roles [51-
55]. Together, these studies suggest a cyclical relation-
ship between fatigue and inactivity, and that it reduces
quality of life and increases participation restrictions.
Thus, there is a need to conduct cross-disciplinary re-
search that fills the existing gap in the MS literature
regarding whether combining fatigue management with
physical activity promotion has beneficial synergistic
effects on increasing quality of life and reducing partici-
pation restrictions in persons with MS.
The proposed interventions are expected to have
beneficial effects on participants regardless of the cause
of MS fatigue. Although the pathophysiology of MS fa-
tigue remains unclear, researchers distinguish between
primary and secondary causes of MS fatigue [14]. Pri-
mary causes of fatigue pertain to MS pathology and
adaptive responses, such as brain lesions, axonal dam-
age, cortical reorganization, and neuroendocrine factors
[56-58]. Secondary factors in fatigue pertain to personal
characteristics that are not specific to MS, such as de-
conditioning and depression. Ultimately, participants in
the proposed study may experience fatigue because of
primary and secondary factors. The fatigue management
program involves teaching compensatory strategies, and
physical activity may mitigate secondary factors asso-
ciated with fatigue [47]. Thus, we expect the FM+ inter-
vention to be the most effective because of its potential
to facilitate engagement in compensatory strategies and
address secondary fatigue factors.
Although physical activity may prevent de-conditioning
and improve other secondary factors associated with fa-
tigue, such as depression, there is limited research on
identifying cost-effective strategies to increase physical
activity levels. Encouraging participants over the phoneto set realistic goals and self-monitor walking behavior
with a pedometer may be a cost-effective and
ecologically-valid strategy for increasing physical activity
behavior in the population with MS. Since the most com-
mon type or mode of physical activity among persons
with MS is walking [6,59], having participants set goals
to increase daily walking steps is a practical method for
increasing physical activity. Furthermore, Stuifbergen
et al. [60,61] have demonstrated the utility of using goal-
setting to promote healthy behaviors in persons with MS.
Locke and Latham contend that goal-setting directs at-
tention toward goal-relevant activities and away from ir-
relevant activities, and helps foster intrinsic motivation
[38]. They posit that personal barriers can impact the ef-
ficacy of goal-setting for motivating behavior change.
Thus, the development of strategies for overcoming such
barriers as fatigue might augment the effect of a goal-
setting approach for increasing physical activity.
Nonetheless, we acknowledge there is the risk that a
walking program may be ineffective in adults with MS,
or that a walking program may result in imprudent risk
for injuries. Cold and icy or hot weather, along with
other environmental factors such as connectivity of side-
walks, could influence individuals’ ability and willingness
to walk. This potential limitation will be addressed by
providing information on how individuals with MS can
safely engage in a walking program on a regular basis.
For example, tips will include taking a cool shower be-
fore engaging in physical activity, wearing a cooling vest
while engaging in physical activity, or walking in a
climate-controlled facility, such as in a mall. We will
monitor the frequency of injuries and exacerbations, as
well as overall symptom severity and function, with a
safety questionnaire. However, moderate-intense phys-
ical activity programs are generally considered to be safe
for individuals with mild to moderate MS symptoms
[62].
Conclusions
This study will build upon the work of Stuifbergen et al.
[60], McAuley et al. [35], and Motl et al. [45] by imple-
menting a minimal-contact telephone-based interven-
tion; the work of Mathiowetz et al. [26] and Finlayson
et al. [63] by evaluating the combined benefits of pro-
moting physical activity and teaching fatigue manage-
ment strategies; and the work of Bombardier et al. [64]
by exploring the effectiveness of changing behavior using
a combination of group teleconferences and one-to-one
calls without any face-to-face contact. This proposed
study represents the largest randomized controlled trial
to examine the effects of a lifestyle physical activity
intervention in people with MS, and the first study to
systematically explore the combined benefits of teaching
fatigue management strategies and promoting physical
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effective, future translational research will involve ex-
ploring strategies to implement it within clinical care
and comparing it to traditional in-person, individualized
rehabilitation interventions.
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